Skip to main content
Caplight Logo









Koru Pharma Co., Ltd.

Koru Pharma Co., Ltd.

Private
SeoulHealthcare & Life Scienceshttps://korupharma.com/

Last Round

Private Equity

May 6, 2026

Est. Valuation

$100M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Koru Pharma Co., Ltd. is a biopharmaceutical company that develops and manufactures medical aesthetic products for anti-aging and skin rejuvenation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Fashion & Beauty

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical aestheticsdermal fillershyaluronic acid fillersskin boostersthread liftsmesotherapynon-surgical aestheticscollagen stimulatorskin rejuvenationK-beautyPLLA stimulatorfacial contouringbiorevitalizationGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Koru Pharma Co., Ltd. Comparables

Compare Koru Pharma Co., Ltd. with similar companies based on industry and business-model similarity.

Koru Pharma Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Laboratoires Vivacy
85%
Prollenium Medical Technologies
83%
Croma-Pharma GmbH
81%

Koru Pharma Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityMay 6, 2026
SecondaryJan 10, 2025

Key People

Founding team and executive leadership

정수헌

Chief Financial Officer

Executive Team

Koru Pharma Co., Ltd. Investors

Notable investors and investment history

Koru Pharma Co., Ltd. investors
InvestorRounds
DSC InvestmentSecondary
KB InvestmentSecondary
LYFE CapitalPrivate Equity
IMM InvestmentSecondary, Private Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 44% MoM.

  • Jul 27, 2026

    Open roles increased to 18, 2.4x the trailing average.

Recent news

Latest coverage and updates

  • attends_eventJun 19, 2026

    Koru Pharma Co. attends event KORU Academy Exclusive Symposium.

Koru Pharma Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Koru Pharma Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Koru Pharma Co., Ltd.'s valuation, stock price, and market status.

Is Koru Pharma Co., Ltd. a public or private company?

Koru Pharma Co., Ltd. is a private company.

What is the current stock price of Koru Pharma Co., Ltd.?

Koru Pharma Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Koru Pharma Co., Ltd. worth (valuation)?

Valuation information for Koru Pharma Co., Ltd. is not publicly available.

Can I buy Koru Pharma Co., Ltd. stock?

Koru Pharma Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Koru Pharma Co., Ltd.'s last funding round?

Funding round information for Koru Pharma Co., Ltd. is not publicly available.

Who are the main investors in Koru Pharma Co., Ltd.?

Investor information for Koru Pharma Co., Ltd. is not publicly disclosed.

Will Koru Pharma Co., Ltd. IPO soon?

No public IPO plans have been announced for Koru Pharma Co., Ltd..

How can I track Koru Pharma Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Koru Pharma Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range65
Year Founded2016
Last FundingMay 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?